Skip to content
2000
Volume 26, Issue 43
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

A growing number of patients with adrenal incidentalomas and subclinical Cushing's syndrome (SCS) led to an increasing number of different guidelines, and diagnostic and treatment recommendations. Excess cortisol secretion in patients with SCS is associated with several comorbidities, such as hypertension, dyslipidemia, type 2 diabetes mellitus, and obesity, which in the long-term increase mortality of these patients. Subtle cortisol secretion affects bone health, quality of life and causes depression, but due to the unapparent clinical features, patients with SCS are often at risk between over and under treatment. This narrative review aimed to summarize the latest recommendations on the approach to the patient with subclinical Cushing’s syndrome.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612826666200813134328
2020-12-01
2025-05-11
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612826666200813134328
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test